Dagens industri reports that one of the research-based pharmaceutical company Camurus's competitors has decided to leave Sweden.
This move could result in Camurus gaining more customers, according to the company's Head of Business Development, who spoke to Dagens industri.
"We're not talking about a huge effect, but if the majority switch to our product, it could have some impact," says Fredrik Joabsson, Head of Business Development at Camurus, in the newspaper.
The competitor in question is the pharmaceutical company Indivior, which, in addition to leaving Sweden, has also exited several other markets, as reported by multiple media outlets.
